Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of bexarotene in adult T-cell leukemia/lymphoma
jRCT2080224172Phase 2Completed
- Sponsor
- Minophagen Pharmaceutical Co., Ltd.
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bexarotene in adult T-cell leukemia-lymphoma (ATLL), sponsored by Minophagen Pharmaceutical Co., Ltd. Started Nov 2018; status: completed.
02
Drugs
bexarotene
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on jRCT2080224172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224172.